Depending on your medical condition and response to treatment, the dosage will be determined
Hypotheses include GIPR-mediated enhancement of GLP-1R sensitivity and independent adipose tissue effects of GIPR agonism
Even at the highest dose of 2.4 mg, where the risk appears greatest, most patients tolerate the medication without developing this side effect
Interestingly, the neural circuits responsible for the metabolic effects of GLP-1R agonism may be distinct from those mediating nausea or malaise (Huang et al., 2024), suggesting that future therapies could be tailored to preserve metabolic benefits while minimizing gastrointestinal side effects
This sulfur-containing group allows glutathione to act as an electron donor
We realized that no one had comprehensively investigated (the) effectiveness and risks of GLP-1RA across all possible health outcomes